Curcumin down-regulates AR gene expression and activation in prostate cancer cell lines

Related Experiment Video

Updated: Sep 29, 2026

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)
08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)

Published on: May 16, 2012

Keiichiro Nakamura1, Yutaka Yasunaga, Takehiko Segawa

  • 1Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.

International Journal of Oncology
|September 20, 2002
PubMed

Insights

Curcumin, a compound found in turmeric, may help treat prostate cancer. It reduces cancer cell growth by down-regulating key proteins involved in cancer development, including the androgen receptor (AR).

Area of Science:

  • Oncology
  • Molecular Biology
  • Natural Compounds

Background:

  • Curcumin, a natural compound from turmeric, is known for its anti-inflammatory and antioxidant properties.
  • Previous research suggests curcumin may inhibit prostate cancer cell proliferation, but the underlying mechanisms require further investigation.

Purpose of the Study:

  • To investigate the effects of curcumin on prostate cancer cell lines.
  • To elucidate the molecular mechanisms by which curcumin influences cell growth, signal transduction, and transforming activities.

Main Methods:

  • Prostate cancer cell lines (LNCaP and PC-3) were treated with curcumin.
  • Analysis of signal transduction pathways and protein expression using transient transfection assays and Western blotting.
  • Assessment of transforming activity through soft agar colony formation assays.

Main Results:

  • Curcumin significantly down-regulated the transactivation and expression of the androgen receptor (AR).
  • Curcumin inhibited key signaling molecules including activator protein-1 (AP-1), nuclear factor-kappaB (NF-kappaB), and CREB-binding protein (CBP).
  • Curcumin reduced the colony-forming ability of prostate cancer cells in soft agar, indicating inhibition of transforming activity.

Conclusions:

  • Curcumin exhibits potential therapeutic effects against prostate cancer.
  • The anti-cancer activity of curcumin is mediated through the down-regulation of AR and associated cofactors (AP-1, NF-kappaB, CBP).
  • These findings support curcumin's role as a potential agent in prostate cancer therapy.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...